IDEXX Laboratories, Inc. (LON:0J8P)

Market Cap	25.16B
Revenue (ttm)	3.11B
Net Income (ttm)	709.20M
Shares Out	n/a
EPS (ttm)	8.52
PE Ratio	35.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151
Average Volume	232
Open	403.14
Previous Close	401.48
Day's Range	400.70 - 407.10
52-Week Range	373.77 - 583.30
Beta	1.50
RSI	51.00
Earnings Date	May 1, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1983
• Employees: 11,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J8P

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD